汉森制药：公司管理层致力于努力推动公司的发展，为投资者创造价值

Group 1 - The core viewpoint of the article is that Hansen Pharmaceutical (002412) acknowledges that the fluctuations in its stock price in the secondary market are influenced by multiple factors, including macro policies, market trends, and investor preferences [1] - The company's management is committed to promoting the company's development and creating value for investors [1]